Intensive blood pressure control in patients with a history of heart failure:The Systolic Blood Pressure Intervention Trial (SPRINT)

Autor: Manan Pareek, Muthiah Vaduganathan, Christina Byrne, Astrid Duus Mikkelsen, Anna Meta Dyrvig Kristensen, Tor Biering-Sørensen, Kristian Hay Kragholm, Massar Omar, Michael Hecht Olsen, Deepak L Bhatt

Publikováno v: Pareek, M, Vaduganathan, M, Byrne, C, Mikkelsen, A D, Kristensen, A M D, Biering-Sørensen, T, Kragholm, K H, Omar, M, Olsen, M H & Bhatt, D L 2022, ' Intensive blood pressure control in patients with a history of heart failure : The Systolic Blood Pressure Intervention Trial (SPRINT) ', European heart journal. Cardiovascular pharmacotherapy, vol. 8, no. 3, pvab085, pp. E12–E14 . https://doi.org/10.1093/ehjcvp/pvab085
Pareek, M, Vaduganathan, M, Byrne, C, Mikkelsen, A D, Kristensen, A M D, Biering-Sørensen, T, Kragholm, K H, Omar, M, Olsen, M H & Bhatt, D L 2022, ' Intensive blood pressure control in patients with a history of heart failure : The Systolic Blood Pressure Intervention Trial (SPRINT) ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 8, no. 3, pp. E12-E14 . https://doi.org/10.1093/ehjcvp/pvab085
Pareek, M, Vaduganathan, M, Byrne, C, Mikkelsen, A D, Kristensen, A M D, Biering-Sørensen, T, Kragholm, K H, Omar, M, Olsen, M H & Bhatt, D L 2022, ' Intensive blood pressure control in patients with a history of heart failure : the Systolic Blood Pressure Intervention Trial (SPRINT) ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 8, no. 3, pp. 321-323 . https://doi.org/10.1093/ehjcvp/pvab085

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb020acddd6d603dc5bdcbccc1c2c02
https://vbn.aau.dk/ws/files/505341053/Pareek_et_al._2022_Intensive_blood_pressure_control_in_patients_with_a_history_of_heart_failure_The_Systolic_Blood_Pressure_Intervention_Trial_SPRINT_.pdf

Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis

Autor: James Yarmolinsky, Virginia Díez-Obrero, Tom G Richardson, Marie Pigeyre, Jennifer Sjaarda, Guillaume Paré, Venexia M Walker, Emma E Vincent, Vanessa Y Tan, Mireia Obón-Santacana, Demetrius Albanes, Jochen Hampe, Andrea Gsur, Heather Hampel, Rish K Pai, Mark Jenkins, Steven Gallinger, Graham Casey, Wei Zheng, Christopher I Amos, International Lung Cancer Consortium, PRACTICAL consortium, MEGASTROKE consortium, George Davey Smith, Richard M Martin, Victor Moreno

Publikováno v: PLoS Medicine, Vol 19, Iss 2, p e1003897 (2022)
Yarmolinsky, J, Díez-Obrero, V, Richardson, T G, Pigeyre, M, Sjaarda, J, Paré, G, Walker, V M, Vincent, E E, Tan, V Y, Obón-Santacana, M, Albanes, D, Hampe, J, Gsur, A, Hampel, H, Pai, R K, Jenkins, M, Gallinger, S, Casey, G, Zheng, W, Amos, C I, International Lung Cancer Consortium, The PRACTICAL Consortium, The MEGASTROKE consortium, Smith, G D, Martin, R M & Moreno, V 2022, ' Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers : A mendelian randomization analysis ', PLOS Medicine, vol. 19, no. 2, e1003897 . https://doi.org/10.1371/journal.pmed.1003897
the PRACTICAL Consortium 2022, ' Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers : A mendelian randomization analysis ', PLoS Medicine, vol. 19, no. 2, e1003897 . https://doi.org/10.1371/journal.pmed.1003897
Dipòsit Digital de la UB
Universidad de Barcelona

BackgroundEpidemiological studies have reported conflicting findings on the potential adverse effects of long-term antihypertensive medication use on cancer risk. Naturally occurring variation in genes encoding antihypertensive drug targets can be us

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58ebdcff10cb8f88caaecd212f39594e
https://doaj.org/article/34b1a0c7008a49a584262cd8aef7a5ec

Albuminuria is associated with an increased prostasin in urine while aldosterone has no direct effect on urine and kidney tissue abundance of prostasin

Autor: Birgül Kurt, Mette Staehr, Pernille B. Lærkegaard Hansen, Gitte R. Hinrichs, Claus Bistrup, Boye L. Jensen, Christina Stolzenburg Oxlund, Per Svenningsen, Mie R. Hansen, Ilona Schwarzensteiner, Ib Abildgaard Jacobsen, Anja Toft, Anne D Thuesen

Publikováno v: Stolzenburg Oxlund, C, Kurt, B, Schwarzensteiner, I, Hansen, M R, Stæhr, M, Svenningsen, P, Jacobsen, I A, Hansen, P B, Thuesen, A D, Toft, A, Hinrichs, G R, Bistrup, C & Jensen, B L 2017, ' Albuminuria is associated with an increased prostasin in urine while aldosterone has no direct effect on urine and kidney tissue abundance of prostasin ', Pfluegers Archiv, vol. 469, no. 5-6, pp. 655–667 . https://doi.org/10.1007/s00424-017-1938-6

The proteinase prostasin is a candidate mediator for aldosterone-driven proteolytic activation of the epithelial sodium channel (ENaC). It was hypothesized that the aldosterone-mineralocorticoid receptor (MR) pathway stimulates prostasin abundance in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6235fd863d3e55514ccd4f982e378325
https://doi.org/10.1007/s00424-017-1938-6

Hydrochlorothiazide use and risk of nonmelanoma skin cancer:A nationwide case-control study from Denmark

Autor: Søren Friis, Anton Pottegård, Sigrún Alba Jóhannesdóttir Schmidt, Lisbet Rosenkrantz Hölmich, David Gaist, Sidsel Arnspang Pedersen

Publikováno v: Arnspang, S, Gaist, D, Johannesdottir Schmidt, S A, Hölmich, L R, Friis, S & Pottegård, A 2018, ' Hydrochlorothiazide use and risk of nonmelanoma skin cancer : A nationwide case-control study from Denmark ', Journal of the American Academy of Dermatology, vol. 78, no. 4, pp. 673-681.e9 . https://doi.org/10.1016/j.jaad.2017.11.042
Pedersen, S A, Gaist, D, Schmidt, S A J, Hölmich, L R, Friis, S & Pottegård, A 2018, ' Hydrochlorothiazide use and risk of nonmelanoma skin cancer : A nationwide case-control study from Denmark ', Journal of the American Academy of Dermatology, vol. 78, no. 4, pp. 673-681.e9 . https://doi.org/10.1016/j.jaad.2017.11.042
Pedersen, S A, Gaist, D, Schmidt, S A J, Holmich, L R, Friis, S & Pottegard, A 2018, ' Hydrochlorothiazide use and risk of nonmelanoma skin cancer : A nationwide case-control study from Denmark ', Journal of the American Academy of Dermatology, vol. 78, no. 4, e9, pp. 673-681 . https://doi.org/10.1016/j.jaad.2017.11.042

Background: Hydrochlorothiazide, one of the most frequently used diuretic and antihypertensive drugs in the United States and Western Europe, is photosensitizing and has previously been linked to lip cancer. Objective: To examine the association betw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a578e3c2877b5f4ae48af119a4838ecf
https://findresearcher.sdu.dk:8443/ws/files/137606525/Hydrochlorothiazide_use_and_risk_of_non_melanoma_skin_cancer.pdf

Terlipressin versus other vasoactive drugs for hepatorenal syndrome

Autor: Rachel W. Winter, Mads Israelsen, Manol Jovani, Alison Goldin, Aleksander Krag, Andrew S. Allegretti, Lise Lotte Gluud

Publikováno v: The Cochrane Library
Israelsen, M, Krag, A, Allegretti, A S, Jovani, M, Goldin, A H, Winter, R W & Gluud, L L 2017, ' Terlipressin versus other vasoactive drugs for hepatorenal syndrome ', Cochrane Database of Systematic Reviews, vol. 2017, no. 9, CD011532 . https://doi.org/10.1002/14651858.CD011532.pub2

Background Hepatorenal syndrome is defined as severe renal failure occurring in people with cirrhosis and ascites. Systematic reviews of randomised clinical trials found that, compared with placebo, terlipressin may reduce mortality and improve renal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c851f96fb2261499e33852264bb0f72
https://doi.org/10.1002/14651858.cd011532.pub2